Immunological analysis of neuromyelitis optica.

Immunological analysis of neuromyelitis optica. - Immunological analysis of neuromyelitis optica.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018107

Enrollment

Registered

2015-07-02

Start date

2015-07-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromyelitis optica spectrum disorder

Interventions

Vein drawing blood

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The NMO patient

Exclusion criteria

Exclusion criteria: The patient who refused this reseach

Design outcomes

Primary

Measure	Time frame
The QOSI score, the ratio of each lymphocyte subset, autoantibody titer.	—

Countries

Japan

Contacts

Public ContactSatoru Tanaka

Saitama medical center, Saitama medical university Neurology

satoru_t@saitama-med.ac.jp049-228-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026